St. Jude Medical, Inc. , a global medical device company, today announced approval from the U.S. Food and Drug Administration for the Allure Quadra™ Cardiac Resynchronization Therapy Pacemaker , which provides additional pacing innovations for physicians to treat patients with heart failure.
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1eEuWy2
via IFTTT
from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/1eEuWy2
via IFTTT
No comments:
Post a Comment